How to Deal with Nausea from Semaglutide — Without Stopping Treatment

The biggest myth: nausea means semaglutide isn't right for you

The most common reason people stop semaglutide early is nausea, and the most common misunderstanding is that nausea is a signal to stop. It usually isn't. The GI effects of semaglutide (nausea, queasiness, occasional vomiting, loose stools) are a direct consequence of the medicine slowing gastric emptying, which is the same mechanism that helps reduce appetite. According to the NHS medicines guidance on semaglutide, these effects are most noticeable at the start of treatment or after a dose step up, and they typically settle within days to a couple of weeks.

The practical adjustments that help are straightforward. Eat smaller portions and chew slowly, a heavy meal shortly after your weekly injection is reliably unpleasant for most people. Stick to bland, lower-fat foods while your system adjusts. Sit upright for a while after eating. Stay well hydrated. Avoid lying down immediately after meals. None of this is complicated, but it does require a bit of deliberate attention in the first few weeks, particularly around dose increases.

What doesn't help: skipping meals to avoid nausea (it often makes it worse), taking anti-sickness tablets routinely without speaking to your prescriber first, or deciding after one bad evening that the medicine isn't for you. Nausea that is severe, persistent, or accompanied by pain that reaches into your back is different and needs prompt medical attention, the MHRA highlighted acute pancreatitis as a known but infrequent risk in its Drug Safety Update communications for GLP-1 medicines. If something feels serious, treat it that way.

How UK private pricing relates to the support you get when nausea hits

Here is where price and side-effect management connect in a way most people don't think about at the point of purchase. UK private treatment for semaglutide is priced per monthly supply, and the range across providers is wide. Since Eli Lilly raised the list price of Mounjaro from September 2025, market prices for GLP-1 medicines more broadly have shifted upward; semaglutide for weight management typically runs from roughly £149 to £375 a month depending on dose and provider, as reported widely in late 2025. Those figures are a starting point, not a ceiling or a floor.

What the headline figure often doesn't reveal is what happens when nausea makes you want to slow your dose increase, ask a question at 8pm on a Sunday, or request a review before your next supply. Some providers charge for prescriber contact. Some don't have aftercare at all. Delivery may be extra. Consultation fees are common. A figure that looks sharp at first glance can quietly accumulate into something larger by the third or fourth month, or leave you without support precisely when you need it most.

If you're trying to understand what semaglutide costs in the UK across the private market, the realistic question isn't what the monthly line-item is, it's what that monthly line-item actually covers. Worth checking before you commit.

What the price includes at nume, and why we're not the cheapest

One price at nume covers the consultation, prescription, your treatment, and next-working-day tracked delivery. There are no add-on fees for aftercare, no extra charge to contact our prescribers when nausea is bad, and no subscription that renews automatically. Every repeat order is clinically re-reviewed before it is approved and dispatched.

We don't compete on price. That's a deliberate decision. The people who leave reviews praising low-cost GLP-1 providers tend not to mention what it was like to have a side-effect question on a Saturday and find no one to ask. Our prescribers are available seven days a week, and your consultation is reviewed by a named clinician, not processed by software. You can verify our pharmacy on the GPhC register at registration number 9012878. If you order before 12pm, dispatch goes the same day once approved, useful if you're on week one of a new dose and want things to land before the weekend.

If you're exploring Wegovy pricing in more detail, our treatment page lays out what is included; current costs are confirmed there rather than in body copy, because prices shift and we don't want to publish something out of date. For a broader look at weight-loss treatment options, that page covers where semaglutide sits relative to other licensed medicines.

Why 'cheapest' is the wrong question when you're managing a prescription medicine

A prescription medicine for weight management isn't a commodity. The substance might be identical across providers, but the clinical infrastructure around it is not. For semaglutide specifically (a Black Triangle medicine still under additional MHRA monitoring) the quality of prescribing, dose-review rigour, and access to a prescriber when things feel off are the variables that matter most to your safety and your results. The MHRA has warned repeatedly about counterfeit weight-loss pens sold through unverified online channels; in 2025 alone, around 20 million doses with an estimated street value of £45 million were seized, and a UK site manufacturing fake tirzepatide pens was raided in Northampton. The pattern is consistent: very low prices and no clinical assessment are the flags. Legitimate private services require a proper prescriber review; that review is part of what you're paying for.

For context on what outcomes people actually achieve, realistic weight-loss figures from semaglutide trials are worth reading before any provider comparison. And if nausea is the specific sticking point in your decision, our Wegovy overview covers the full picture, including what clinical trial participants reported and how prescribers approach dose titration to reduce GI burden. If you've already decided Wegovy is right for you, it's worth checking whether there's a Wegovy deal currently available before you place your order, and comparing across suppliers is easier when you know which chemist offers the most competitive price for Wegovy. The goal is treatment that works, not treatment that was simply the lowest figure on the page. A small saving in month one isn't the measure that keeps you safe in month six.